Battle Royale: Small molecules vs. biologics

The Inflation Reduction Act (IRA) allows the Centers for Medicare and Medicaid Services to negotiate drug prices. However, CMS can only negotiated drug prices 9 years after drug approval for small molecules and 13 years after approval for large molecules. Why the difference? Do biologic treatments produce superior health benefits for patients? This is the…

Read More

Aetna Exec: Payers Need to Stop Making Behavioral Health Providers Jump Through Hoops In Order to Participate in Value-Based Care

Value-based care contracting is especially difficult for behavioral health providers, Taft Parsons III, chief psychiatric officer at CVS Health/Aetna, pointed out during a conference this week. The post Aetna Exec: Payers Need to Stop Making Behavioral Health Providers Jump Through Hoops In Order to Participate in Value-Based Care appeared first on MedCity News.

Read More

Online patient scheduling software: what providers need to know

Outdated scheduling systems, endless phone calls and clunky user digital interfaces cause friction – for both patients and staff. The result? Frustrated patients, no-shows, unused appointment time slots and a hit to bottom lines. Patients want to see their provider quickly, and they don’t want to jump through hoops to make an appointment. Online patient…

Read More